Supercritically dried superparamagnetic mesoporous silica nanoparticles for cancer theranostics

Area of Science:

• Nanotechnology
• Materials Science
• Biomedical Engineering

Background:

• Development of multifunctional platforms for cancer theranostics is crucial.
• Superparamagnetic iron oxide nanoparticles (IO) offer unique properties for biomedical applications.
• Mesoporous silica (mSiO2) provides a versatile shell for drug delivery and imaging.

Purpose of the Study:

• To synthesize and characterize core-shell nanocomplexes of superparamagnetic iron oxide and mesoporous silica.
• To evaluate their potential as T2 contrast agents for magnetic resonance imaging (MRI).
• To assess their efficacy as drug delivery vehicles for anticancer drugs.

Main Methods:

• Synthesis of iron oxide cores via thermal decomposition or microemulsion.
• Coating with mesoporous silica shell using sol-gel methods.
• Characterization using VSM for magnetic properties and NMR relaxometry for contrast agent potential.
• Drug loading with epirubicin and in vitro drug release studies.
• Cytotoxicity assessment of drug-loaded nanoparticles.

Main Results:

• Three distinct core-shell nanocomplexes (IO-OAm/mSiO2, IO-APTES/mSiO2, IO/SiO2/mSiO2) were successfully prepared.
• Superparamagnetic behavior confirmed by VSM, with varying saturation magnetization (Ms) values.
• High r2 relaxivity values (up to 63.93 s-1·mM-1 Fe) indicate potential as T2 contrast agents.
• Consistent epirubicin loading (~3%) and varying drug release profiles (19-31%).
• Promising cytotoxicity results for drug-loaded nanoparticles against cancer cells.

Conclusions:

• The synthesized IO/mSiO2 nanocomplexes are multifunctional platforms suitable for cancer theranostics.
• These nanoparticles exhibit excellent magnetic properties and potential as T2 contrast agents.
• They demonstrate significant promise as effective carriers for anticancer drug delivery, warranting further investigation.